Overview

Investor contact
Media contact

Company Profile

Liferna is advancing a diversified portfolio of therapies designed to transform outcomes for patients with autoimmune, fibrotic, and other serious diseases. The company is developing innovative RNA therapeutics, monoclonal antibodies, cell therapies, and small molecules targeting key disease pathways.

Guided by deep scientific insight and a capital-efficient development model, Liferna is committed to accelerating the delivery of meaningful, life-changing therapies to patients worldwide.

To learn more about Liferna, visit Liferna.com and follow us on X (Twitter), LinkedIn and Instagram.

NASDAQ: LFRN
$22.43
May 4, 2026 12:18 PM EDT

View Stock Performance »

📰

Recent News »

📅

Events »

📄

Corporate Presentations »